BGI Genomics Co., Ltd. (SHE:300676)
China
· Delayed Price · Currency is CNY 59.21
-1.90 (-3.11%)
Feb 28, 2025, 2:45 PM CST
BGI Genomics Revenue
BGI Genomics had revenue of 954.49M CNY in the quarter ending September 30, 2024, a decrease of -10.93%. This brings the company's revenue in the last twelve months to 4.03B, down -29.00% year-over-year. In the year 2023, BGI Genomics had annual revenue of 4.35B, down -38.33%.
Revenue (ttm)
4.03B
Revenue Growth
-29.00%
P/S Ratio
5.93
Revenue / Employee
1.07M
Employees
3,752
Market Cap
22.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 4.35B | -2.70B | -38.33% |
| Jan 1, 2023 | 7.05B | 287.01M | 4.24% |
| Jan 1, 2022 | 6.77B | -1.63B | -19.42% |
| Dec 31, 2020 | 8.40B | 5.60B | 199.86% |
| Dec 31, 2019 | 2.80B | 264.01M | 10.41% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| Jiangsu Hengrui Medicine | 26.00B |
| WuXi AppTec | 38.50B |
| Aier Eye Hospital Group | 20.62B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Shanghai United Imaging Healthcare | 10.93B |
| Yunnan Baiyao Group Co.,Ltd | 39.34B |
| Beijing Wantai Biological Pharmacy Enterprise | 2.49B |